The present invention is a multilayered composite comprising porous metal oxide particles that are covalently bonded by way of inorganic ether groups to one or more sites of a first polyhydroxyl-functionalized polymer. This first polymer is in turn covalently bonded by way of inorganic ether groups to one or more sites of a second polyhydroxyl-functionalized polymer. The multilayered composites can be prepared by contacting porous inorganic-oxide particles with a sufficient amount of OH-reactive crosslinking agent to form metal oxide particles imbibed with the crosslinking agent, and then contacting the inorganic-oxide particles with a solution of polyhydroxyl-functionalized polymer under reactive conditions.

The present invention is a multilayered composite comprising porous metal oxide particles that are covalently bonded by way of inorganic ether groups to one or more sites of a first polyhydroxyl-functionalized polymer. This first polymer is in turn covalently bonded by way of inorganic ether groups to one or more sites of a second polyhydroxyl-functionalized polymer. The multilayered composites can be prepared by contacting porous inorganic-oxide particles with a sufficient amount of OH-reactive crosslinking agent to form metal oxide particles imbibed with the crosslinking agent, and then contacting the inorganic-oxide particles with a solution of polyhydroxyl-functionalized polymer under reactive conditions.

Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics.

This document provides polymer compositions (e.g., biopolymer compositions) and coatings. For example, methods and materials related to polymer compositions (e.g., biopolymer compositions) and coatings as well as methods and materials for making and using such compositions (e.g., biopolymer compositions) and coatings are provided.

A manufacturing process for an anti-dust and easily dispersible carbon black pigment is disclosed herein. The pigment is convenient to handle and does not generate potentially hazardous airborne particles during transportationor duringany suitable processing conditions employed in end applications in the relevant industry including cosmetics, paint or ink.

A method for preparing a deacidifying and reinforcing agent for a cellulose acetate film includes steps of: ultrasonically dispersing a nanometer alkaline oxide into an ethyl cellulose n-butanol solution, so as to form a nanometer alkaline oxide suspension, then adding a mixture of E51 EPOXY RESIN and a curing agent thereof; wherein the nanometer alkaline oxide is a nanometer magnesium oxide, a nanometer cerium oxide, a nanometer magnesium hydroxide, a nanometer potassium carbonate, a nanometer calcium hydroxide or a nanometer barium hydroxide. A method for using the deacidifying and reinforcing agent includes steps of: evenly applying the deacidifying and reinforcing agent on a surface of a cellulose acetate film.

A method for preparing a deacidifying and reinforcing agent for a cellulose acetate film includes steps of: ultrasonically dispersing a nanometer alkaline oxide into an ethyl cellulose n-butanol solution, so as to form a nanometer alkaline oxide suspension, then adding a mixture of E51 EPOXY RESIN and a curing agent thereof; wherein the nanometer alkaline oxide is a nanometer magnesium oxide, a nanometer cerium oxide, a nanometer magnesium hydroxide, a nanometer potassium carbonate, a nanometer calcium hydroxide or a nanometer barium hydroxide. A method for using the deacidifying and reinforcing agent includes steps of: evenly applying the deacidifying and reinforcing agent on a surface of a cellulose acetate film.

The present invention provides a two-component bioink including a first solution and a second solution separately, wherein (i) the first solution includes a first biopolymer to which a first chemical functional group is introduced, and the second solution includes a second biopolymer to which a second chemical functional group able to chemically bond with the first chemical functional group is introduced; or (ii) the first solution includes a third biopolymer having a first electrostatic functional group, and the second solution includes a fourth biopolymer having a second electrostatic functional group able to physically bond with the first electrostatic functional group, a 3D biomaterial including the same, and a method for preparing the same.

A silver nanoparticle composite or a copper nanoparticle composite is formed in which the silver nanoparticle composite has silver nanoparticles, and both (a) one or more polymers and ascorbic acid adsorbed on the silver nanoparticles, wherein the (a) one or more polymers are selected from one or more of cellulose acetate, cellulose acetate phthalate, cellulose acetate butyrate, cellulose acetate propionate, cellulose acetate trimellitate, hydroxypropylmethyl cellulose phthalate, methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose, and carboxymethyl cellulose. Copper nanoparticle composite are similarly formed in which both the (a) one or more polymers and ascorbic acid are adsorbed on the copper nanoparticles.

A silver nanoparticle composite or a copper nanoparticle composite is formed in which the silver nanoparticle composite has silver nanoparticles, and both (a) one or more polymers and ascorbic acid adsorbed on the silver nanoparticles, wherein the (a) one or more polymers are selected from one or more of cellulose acetate, cellulose acetate phthalate, cellulose acetate butyrate, cellulose acetate propionate, cellulose acetate trimellitate, hydroxypropylmethyl cellulose phthalate, methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose, and carboxymethyl cellulose. Copper nanoparticle composite are similarly formed in which both the (a) one or more polymers and ascorbic acid are adsorbed on the copper nanoparticles.